Cargando…

Identification of tumor associated immune responses against brachyury, a transcription factor and driver of EMT, in chordoma patients receiving a yeast-brachyury vaccine (gi-6301)

Detalles Bibliográficos
Autores principales:	Donahue, Renee N, Grenga, Italia, Lepone, Lauren, Gulley, James L, Heery, Christopher R, Madan, Ravi A, Rodell, Timothy C, Schlom, Jeffrey, Farsaci, Benedetto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288479/ http://dx.doi.org/10.1186/2051-1426-2-S3-P148

Ejemplares similares

Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
por: Heery, Christopher R, et al.
Publicado: (2015)

Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable Chordoma
por: DeMaria, Peter Joseph, et al.
Publicado: (2021)

PD-1 and PD-L1 expression on PBMC subsets in normal individuals and cancer patients
por: Lepone, Lauren, et al.
Publicado: (2014)

Flow-cytometry phenotypic assessment of immune cell subsets reflecting function for the identification of breast cancer patients receiving vaccine plus docetaxel with longer progression-free survival
por: Grenga, Italia, et al.
Publicado: (2013)

Digital immunohistochemistry analysis of intratumoral immune infiltrates in prostate cancer patients treated with intraprostatic/systemic PSA-TRICOM vaccine
por: Farsaci, Benedetto, et al.
Publicado: (2013)

PD-L1 and MHC-I expression in 19 human tumor cell lines and modulation by interferon-gamma treatment
por: Grenga, Italia, et al.
Publicado: (2014)

Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression
por: Grenga, Italia, et al.
Publicado: (2015)

From Notochord Formation to Hereditary Chordoma: The Many Roles of Brachyury
por: Nibu, Yutaka, et al.
Publicado: (2013)

Small-molecule targeting of brachyury transcription factor addiction in chordoma
por: Sharifnia, Tanaz, et al.
Publicado: (2019)

Tissue Microarray Immunohistochemical Detection of Brachyury Is Not a Prognostic Indicator in Chordoma
por: Zhang, Linlin, et al.
Publicado: (2013)

Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish
por: D'Agati, Gianluca, et al.
Publicado: (2019)

Effects of tyrosine kinase inhibitors alone or in combination with vaccine on tumor-infiltrating myeloid cells
por: Donahue, Renee N, et al.
Publicado: (2013)

Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody
por: Donahue, Renee N., et al.
Publicado: (2017)

Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types
por: Lepone, Lauren M., et al.
Publicado: (2016)

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
por: DeMaria, Peter J, et al.
Publicado: (2021)

Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas
por: WANG, KE, et al.
Publicado: (2015)

Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells
por: Lepone, Lauren, et al.
Publicado: (2015)

Upregulation of oncogenic MUC1 by the EMT transcription factor brachyury mediates immunotherapy-resistance in tumor cells
por: David, Justin M, et al.
Publicado: (2015)

Brachyury, a driver of tumor invasiveness and resistance to multiple therapies, is a novel immunotherapy target
por: Palena, Claudia, et al.
Publicado: (2013)

The role of oncogenic MUC1-C in brachyury-induced immunotherapy resistance
por: David, Justin, et al.
Publicado: (2014)

Brachyury: A Diagnostic Marker for the Differential Diagnosis of Chordoma and Hemangioblastoma versus Neoplastic Histological Mimickers
por: Barresi, Valeria, et al.
Publicado: (2014)

Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury
por: Williamson, Laura M., et al.
Publicado: (2021)

The Brachyury Gly177Asp SNP Is not Associated with a Risk of Skull Base Chordoma in the Chinese Population
por: Wu, Zhen, et al.
Publicado: (2013)

Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity
por: Sheppard, Hadley E., et al.
Publicado: (2021)

Quantitative Dissection of the Proximal Ciona brachyury Enhancer
por: Shimai, Kotaro, et al.
Publicado: (2022)

Tumor vascular normalization as a strategy to potentiate effectiveness of therapeutic vaccines
por: Farsaci, Benedetto, et al.
Publicado: (2014)

A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses
por: Grenga, Italia, et al.
Publicado: (2016)

A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
por: Gatti‐Mays, Margaret E., et al.
Publicado: (2019)

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
por: Bilusic, Marijo, et al.
Publicado: (2021)

Brachyury, Foxa2 and the cis-Regulatory Origins of the Notochord
por: José-Edwards, Diana S., et al.
Publicado: (2015)

The Roles of Embryonic Transcription Factor BRACHYURY in Tumorigenesis and Progression
por: Chen, Ming, et al.
Publicado: (2020)

Brachyury engineers cardiac repair competent stem cells
por: Li, Mark, et al.
Publicado: (2020)

Conserved enhancers control notochord expression of vertebrate Brachyury
por: Kemmler, Cassie L., et al.
Publicado: (2023)

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)
por: Boyerinas, Benjamin, et al.
Publicado: (2013)

Inhibition Of Glycogen Synthase Kinase 3 Beta Suppresses The Growth And Survival Of Skull Base Chordoma Cells By Downregulating Brachyury Expression
por: Yan, Xudong, et al.
Publicado: (2019)

Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
por: Hamilton, Duane H., et al.
Publicado: (2014)

Genomic Targets of Brachyury (T) in Differentiating Mouse Embryonic Stem Cells
por: Evans, Amanda L., et al.
Publicado: (2012)

Conserved enhancer logic controls the notochord expression of vertebrate Brachyury
por: Kemmler, Cassie L., et al.
Publicado: (2023)

Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack
por: Grenga, Italia, et al.
Publicado: (2015)

Functional comparison of distinct Brachyury(+) states in a renal differentiation assay
por: Zhou, Jing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gtciome137co8o4n0b4u660tfq